• Medientyp: E-Artikel
  • Titel: Accuracy of intraoperative frozen section in the diagnosis of ovarian neoplasms: Experience at a tertiary oncology center
  • Beteiligte: Maheshwari, Amita; Gupta, Sudeep; Kane, Shubhada; Kulkarni, Yogesh; Goyal, Lt Col Bhupesh Kumar; Tongaonkar, Hemant B
  • Erschienen: Springer Science and Business Media LLC, 2006
  • Erschienen in: World Journal of Surgical Oncology
  • Sprache: Englisch
  • DOI: 10.1186/1477-7819-4-12
  • ISSN: 1477-7819
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>Epithelial ovarian neoplasms are an important cause of morbidity and mortality in women. The surgical management of ovarian neoplasms depends on their correct categorization as benign, borderline or malignant. This study was undertaken to evaluate the accuracy of intra-operative frozen section in the diagnosis of various categories of ovarian neoplasms.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>Intraoperative frozen section diagnosis was retrospectively evaluated in 217 patients with suspected ovarian neoplasms who underwent surgery as primary line of therapy at our institution. This was compared with the final histopathologic diagnosis on paraffin sections.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>In 7 patients (3.2%) no opinion on frozen section was possible. In the remaining 210 patients frozen section report had a sensitivity of 100%, 93.5% and 45.5% for benign, malignant and borderline tumors. The corresponding specificities were 93.2%, 98.3% and 98.5% respectively. The overall accuracy of frozen section diagnosis was 91.2%. The majority of cases of disagreement were in the mucinous and borderline tumors.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>Intraoperative frozen section has high accuracy in the diagnosis of suspected ovarian neoplasms. It is a valuable tool to guide the surgical management of these patients and should be routinely used in all major oncology centers.</jats:p> </jats:sec>
  • Zugangsstatus: Freier Zugang